Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Entity

Biomedica

Tracked across 2 events · 12 articles · First seen Jul 13, 2026 · Last active Sep 15, 2026

Sentiment
20
Attention
2
Events
2
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Business
Biomedica. issued a corrected press release on September 14, 2026, fixing the exchange ratio for its proposed merger with Zoar Limited. The original September 11, 2026 release incorrectly stated that Impact stockholders would receive one…
Impact: Impact Biomedical is the central entity, correcting its merger exchange ratio and approving a 1-for-12.62 reverse stock split to support its proposed combination with Zoar Limited and NYSE American listing objectives. The clarification reduces uncertainty but the stock remains speculative.
Sep 15, 2026 · 6 articles
2 30
Business
Impact: Biomedica gains exclusive distribution rights for AGAMREE in five additional countries, strengthening its rare disease portfolio in emerging markets.
Jul 13, 2026 · 6 articles
80 Biomedica approved reverse stock splitImpact Biomedical Zoar...
70 Biomedica corrected merger exchange ratio Zoar LimitedImpact Biomedical Zoar...
40 Biomedica approved reverse stock splitImpact Biomedical Zoar...
ERGEN INTELLIGENCE
Track Biomedica live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.